INI. L. Nastashenko

I. L. Nastashenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. L. Nastashenko has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modern approaches to the diagnosis of precancerous conditions of the gastric mucosa: a literature review

    by Nazarii Sikorskyi, Ihor Nastashenko

    Precancerous conditions of the gastric mucosa — atrophic gastritis, intestinal metaplasia, and dysplasia — are key components of the gastric carcinogenesis cascade and determine the need for timely diagnosis and rational surveillance. This review summarizes current approaches to the detection and risk stratification of precancerous gastric lesions, with particular emphasis on the MAPS III recommendations. It discusses the capabilities of white-light endoscopy and image-enhanced endoscopy (virtual chromoendoscopy), the principles of targeted and systematic biopsy according to the Sydney protocol, as well as the role of the standardized histological staging systems OLGA/OLGIM and the endoscopic grading system for intestinal metaplasia, EGGIM, in predicting the risk of gastric cancer. Special attention is paid to the practical aspects of implementing these approaches in Ukraine, including the availability of technologies, the need for endoscopist training, ensuring the quality of morphological verification, and the organization of patient referral pathways. This review may be useful for unifying diagnostic strategies and improving the effectiveness of secondary prevention of gastric cancer in real-world clinical practice.

  • Open Access

    Complications of surgical treatment for esophageal leiomyoma: a case series

    by Ye. Kozak, Yu. Kondratskyi, I. Nastashenko, O. Dobrzhanskyi, M. Pepenin, A. Kolesnyk, Ye. Shudrak, A. Horodetskyi, V. Turchak, N. Koval, et al.

    Esophageal leiomyomas are the most common benign tumors of the esophagus. While surgical resection is the definitive treatment for symptomatic cases, it carries a risk of postoperative complications. This study presents a case series on the surgical management of esophageal leiomyomas, with a particular emphasis on postoperative complications and their management. This retrospective case series, conducted at the National Cancer Institute (Kyiv, Ukraine), analyzed patients who underwent surgical treatment for symptomatic esophageal leiomyoma between 2021 and 2024 and developed postoperative complications classified as Clavien-Dindo grade III or higher. Data were collected from medical records, including demographics, tumor charac­teristics, surgical details, postoperative course, complications, management strategies, and outcomes. The total number of observations was n=3. Three cases with Clavien-Dindo III-IV postoperative complications were analyzed. Comp­lications included anastomotic leakage following Ivor Lewis esophagectomy (managed with endoscopic stenting and endoscopic vacuum therapy – EVT), esophageal perforation during enucleation leading to mediastinitis (managed with stenting and endoscopic vacuum therapy), and a complex case involving hemopericardium, post-cardiac arrest syndrome, peritonitis and diaphragmatic herniation requiring multiple reinterventions. Despite the severity of these complications, multidisciplinary management led to complete recovery of all patients. Histopathological evaluation confirmed benign leiomyoma in all cases. Surgical management of esophageal leiomyomas, particularly for large tumors, is often associated with significant postoperative complications. While minimally invasive techniques may reduce these risks, they do not eliminate them entirely. Endoscopic therapy plays a critical role in the non-surgical management of anastomotic leakage and esophageal perforation. Vigilant postoperative monitoring and a multidisciplinary approach are essential for achieving favorable outcomes in these complex cases.

  • Open Access

    Evaluation of different methods of endoscopic papillectomy for adenomas of the major duodenal papilla

    by I. L. Nastashenko, Y. M. Kondratskyi, K. V. Kopchak, Y. O. Svichkar, I. O. Ukrainets, A. V. Kolesnyk, Y. A. Shudrak, O. Y. Dobrzhanskyi, M. O. Pepenin, A. V. Horodetskyi

    Objective – to assess the outcomes of endoscopic papillectomy (EP) using standard techniques, as well as to develop and implement novel surgical intervention approaches. Materials and methods. Between 2021 and 2024, the Department of Interventional Endoscopy at the National Cancer Institute performed EP for adenoma of the major duodenal papilla (MDP) on 19 patients, 10 women (52.63%) and 9 men (47.37%), aged 24 to 78 years, with a mean age of 45.6 years. We observed clinical signs of biliary obstruction and cholangitis in the majority of cases (2 (63.15%)). Results. 10 patients (52.63%) with tumours <1.0 cm underwent the standard procedure of en‑bloc loop resection (Group 1). To prevent intraoperative and postoperative complications, we developed and implemented a two‑stage EP procedure in 6 (31.57%) cases (Group 2). In 3 (15.78%) patients with tumours ranging from 5.0 to 8.0 cm, the piecemeal approach was used to remove all fragments from the area of the neoplasm that reached into the intestinal lumen (Group 3). After a three‑month follow‑up, 2 patients (10.5%) from Group 3 had a recurrence of an adenoma of the MDP. Both cases required loop diathermy excision for recurrent neoplasms and stent removal. Routine tests at 3 and 6 months revealed no evidence of disease progression. Conclusions. The topographic and anatomical characteristics of the MDP area determine the complexity of surgical interventions for patients with neoplasms. The novel EP approach minimizes the risks associated with both early and late postoperative complications. The outcomes achieved by employing EP in the treatment of patients with MDP adenomas support its recommendation as the primary approach at specialized centers.

  • Open Access

    ЛІКУВАННЯ НЕСПРОМОЖНОСТІ СТРАВОХІДНО-ТОНКОКИШКОВОГО АНАСТОМОЗУ ПІСЛЯ ГАСТРЕКТОМІЇ САМОРОЗШИРЮВАЛЬНИМИ СТЕНТАМИ

    by О. Ю. Добржанський, Ю. М. Кондрацький, І. О. Українець, І. Л. Насташенко, Я. О. Свічкар, А. В. Колесник, Є. А. Шудрак, М. О. Пепенін, А. В. Городецький, В. О. Турчак

    Мета роботи: визначити вплив стентування неспроможності стравохідно-тонкокишкових анастомозів на кількість інвалідизуючих хірургічних інтервенцій. Матеріали і методи. Було проаналізовано дані пацієнтів, які отримали хірургічне лікування раку шлунка за період з 2018 р. до 2022 р. у ДНП «Національний інститут раку». 613 особам виконали гастректомію. Неспроможність стравохідно-тонкокишкового анастомозу виникла у 48 (7,8 %) хворих. Першу групу склали 9 (18,7 %) пацієнтів, які мали лише рентгенологічні ознаки неспроможності. Другу – 19 (39,5 %) хворих із неспроможністю (50 % окружності). Результати. Стентування, як основний метод лікування, проведено у 16 (75 %) пацієнтів, 4 хворих відмовились від процедури. У пацієнтів із третьої і четвертої груп у 6 випадках проведено повторні операції в обсязі операції Торека. У 70 % пацієнтів, яким встановлювали SEMS, досягнуто повного загоєння. Саморозширювальні стенти добре зарекомендували себе як паліативний метод при раку стравоходу з дисфагією III–IV ст. Результати цього дослідження підтверджують їхню ефективність у лікуванні неспроможності стравохідно-тонкокишкового анастомозу (СТА) після гастректомії. Висновки. Використання саморозширювальних металевих стентів (SEMS) дає можливість успішно лікувати неспроможність анастомозу після гастректомії, що свідчить про безпечність методу. Можливість уникнути інвалідизуючих хірургічних втручань свідчить про перевагу перед хірургічними методами лікування. Ендоскопічне стентування потребує подальшого впровадження в клінічну практику та проведення подальших досліджень.

  • Open Access

    EVALUATION OF THE CHARACTER OF MICROBIAL FLORA AT THE STAGES OF TREATMENT IN PATIENTS WITH MALIGNANT OBSTRUCTIVE JAUNDICE

    by O.I. Dronov, І.о. Кovalska, I.L. Nastashenko, L.V. Levchenko, I.A. Shchigel, M.O. Onishchenko, A.O. Malish

    Relevance. The feasibility of preoperative billiary decompression (PBD) remains controversial in patients with malignant billiary obstruction (MOJ), due to the increased risk of multidrug-resistant (MDR), in most cases, catheter-associated microflora and postoperative infection complications. Analysis of biliary infection (BI) and its antibiotic sensitivity is an important aspect of clinical management of patients with resectable tumors of the pancreatobiliary region, which will improve treatment outcomes and reduce postoperative complications. Objective: to assess the nature of the microbial flora at the stages of treatment in patients with MOJ. Мaterials and methods. Prospective single-center cohort study of 136 patients with OJ. Patients were divided into two groups depending on the conduct of biliary decompression in the preoperative stage: group A (n = 84) – patients who underwent biliary decompression; group B (n = 52) – patients who did not perform biliary decompression. Collection of material (bile, drainage) for bacteriological examination was carried out in group A in three stages: 1) during PBD (stage I); 2) during the main surgery – ductus choledochus or endobiliary stent culture (stage II – intraoperative) and in the postoperative period for 3-5 days – culture of exudate from the drainage lumen (stage III – postoperative). In group B, material collection was performed – intraoperatively and postoperatively. The object of the study – microbial isolates, which were isolated in the above terms from the bile, which were identified by conventional methods of bacteriological laboratory. Aerobic and facultative anaerobic flora were studied. The taxonomic structure of microorganism (MO) was assessed by the level of acquired antimicrobial resistance, which is stratified by the European Center for Disease Control. During the bacteriological study, the sensitivity of MO to the following antibiotics was tested: ampicillin-sulbactam, ceftazidime, cefoperazone-sulbactam, ciprofloxacin, levofloxacin, piperacillin-tazobactam, meropenem, vancomycin. Results. BI identified in I stage of the study was represented by monomicrobial in 54.8% of patients and in 45.2% of cases by polymicrobial flora. At the II and III stages of treatment, mixed flora prevailed - 89.3% and 85.7% of cases, respectively. In group A, E. coli was most often sown at the PDB stage (44.5%). E.coli (34.1% and 26.8%) and Kl.pneumoniae were sown most often at the intra- and postoperative stages (20.8% and 28.0%). In group B, monomicrobial flora was presented in 96.2% of cases at the intraoperative stage, while in the postoperative period only in 42.3% of cases. The flora that prevailed in stages II-III of group B was represented by E. coli (31.5% and 29.4%), E. faecalis (18.5% and 15.3%), C.frendii (16.7% and 11.8%). Conclusions. Bacterial infection that causes cholangitis in patients with MOJ, detected primarily during interventional methods of biliary decompression is not a complication. PBD is a risk factor for MDR flora. Each additional day with biliary drainage increases the probability of developing antibiotic resistance by HR 0.17 (95% ВІ 0.07- 0.4), p<0,001 at endobilliary stent placement, and at percutaneous transhepatic biliary drenage by HR 0.59 (95% CI 0.95-0.98), p <0.042. Routine performance of bile culture, knowledge of nosocomial microbial background and indicators of its resistance, the primary method of Gram staining allows the use of early targeted antibiotic therapy, which prevents the development of MDR flora and improves the quality of the postoperative period. Strict adherence to escalation antibiotic therapy scheme at each stage of treatment can prevent the development of MDR flora. The development of new techniques to prevent the development of stent-associated colonization of MO is an important step in preventing bacteriobilia.

  • Open Access

    Experimental investigation of peculiarities for impact of a sorption action preparation silicon dioxide on infectious agents of cholangitis

    by O. I. Dronov, I. O. Kovalska, I. L. Nastashenko, T. O. Kondratiuk, L. V. Levchenko

    Objective. Determination of impact of combination, consisted of 3% solution of silicon dioxide and antibacterial preparations, on bacterial cultures of S. aureus, P. aeruginosa, E. coli. Materials and methods. Clean cultures of bacteria, kept in Collection of Microorganisms in Department of Microbiology and Immunology of Training–Scientific Centre «Іnstitute of Biology and Medicine» of Taras Shevchenko National University: S. aureus (Rosenbach, 1884), P. aeruginosa (Schröter, 1872; Migula, 1900), E. coli (Migula, 1895; Castellani і Chalmers, 1919) were applied. Action of antibacterial preparations cefoperazon, cefoperazon–sulbactam, ampicillin–sulbactam, amicacin, as well as enterosorbent 3% solution of silicon dioxide, was investigated. In the investigation the impact of antibacterial preparations and silicon dioxide together with antibacterial preparations on test–cultures of bacteria was studied, using broth and agarised medium of Muller–Hinton. Results. The data, obtained in the investigation, trust efficacy of combined application of 3% solution of silicon dioxide, owing sorption capacity, with antibacterial preparations in reduction or elimination of subsequent growth of bacterial test–cultures of S. aureus, P. aeruginosa, E. coli. Combination of 3% solution of silicon dioxide with ampicillin–sulbactam in dilutions 64 and 32 mg/l promotes reduction of the E. coli growth on surface of agarised medium in comparison with the investigation variant without application of 3% solution of silicon dioxide. While polyresistence of P. aeruginosa revealed, 3%solution of silicon dioxide together with cefoperazon–sulbactam in concentrations 8 and 16 mg/l and ceftazidime in concentrations 8, 16, 32, 64 mg/l guarantees bactericidal effect for this microorganism. Growth of P. aeruginosa while application of 3% solution of silicon dioxide in combination with ampicillin–sulbactam in dilutions 8, 16, 32, 64 mg/l was arrested. Application of 3% solution of silicon dioxide in combination with amicacin–sulbactam 16 mg/l inhibits the S. aureus growth, what is observed, when combination of 3% solution of silicon dioxide with amicacin in dilutions 8, 16 mg/l and cefoperazon–sulbactam in dilutions 8, 16 mg/l are exploited. Growth of the microorganism do not evolve in variants of the investigation without 3% solution of silicon dioxide, as well as with him, if amikacin is applied in concentrations 64 and 32 mg/l. Conclusion. The biliary ducts drainage in obturative jaundice of tumoral genesis and subsequent presence of drainage (internal or external) constitute the main risk factors for their colonization by multiresistant microorganisms. At the same time, the biliary ducts drainage in combination with antibioticotherapy is estimated as an urgent method for control of the infection primary focus in an acute cholangitis. Establishing of procedure for application of 3% solution of silicon dioxide in combination with certain groups of antibacterial preparations for microorganisms revealed constitute important measure for bacteriobilia prophylaxis. The further investigations conduction with wider spectrum of antibacterial preparations and 3% solution of silicon dioxide for control of clinically significant species of microorganisms is necessary and perspective.

  • Open Access

    Problematic issues of endoscopic biliary stenting

    by A. I. Dronov, I. L. Nastashenko, Yu. P. Bakunets, P. P. Bakunets, L. V. Levchenko

    Objective. To study the results of endoscopic biliary stenting (EBS) for biliary obstruction of various genesis to determine the problematic issues of the procedure and possibility of its efficacy raising. Materials and methods. Experience of conduction of 5748 endoscopic transpapillary interventions in 2010 - 2017 yrs was analyzed: endoscopic papillosphincterotomy was performed in 2919 (50.8%) observations, stenting of biliary ducts - in 379 (6.6%). In 296 (78.1%) observations plastic stents (PS) were introduced, while in 83 (21.9%) – the self-expanding metallic stents. Results. Of 208 patients, in whom primary temporary EBS was performed for tumoral biliary obstruction, using PS, in 153 (73.6%) the next stage of treatment have constituted elective operation in 10 - 14 days after elimination of hyperbilirubinemia, signs of cholangitis, additional examination and determination of the intervention volume. Among these patients in 56 (36.6%) radical operations were performed, and in 97 (63.4%) – palliative operations. In 47 patients PS for closure of external biliary fistula (EBS) PS was introduced: in 13 (27.7%) – for tubular stenosis of distal part of common biliary duct, in 7 (14.9%) – for insufficiency of sutures of common biliary duct (after choledocholithotomy), in 14 (29.8%) – for intraoperative damages of extrahepatic biliary ducts, in 5 (10.6%) – for presence of Luschka channels, in 8 (17.0%) – for a state after hepatic resection, echinococectomy. Presence of concrements, which due to some reasons were not removed endocopically, in environment of purulent cholangitis have constituted the indication for performance of EBS in 24 (8.1%) observations, chronic pancreatitis, complicated by obturation jaundice – in 9 (3.0%). Correction of iatrogenic damages of biliary ducts with development of their partial strictures, EBF, using EBS with introduction of PS, were performed in 8 (2.7%) patients. Conclusion. The necessity exists to study the treatment results in patients, suffering biliary obstruction of various genesis, to determine problematic issues of the main procedures and possibilities of their efficacy raising.


  • Open Access

    Surgical treatment of patients, suffering an acute biliary pancreatitis and biliary hypertension

    by О. І. Dronov, І. L. Nastashenko, Ya. М. Susak, R. S. Tsymbalyuk, І. О. Тyulyukin

    Objective. To improve the results of treatment in patients, suffering an acute biliary pancreatitis with biliary hypertension, applying individual approach in choosing surgical procedure in early phase of the disease. Маterials and methods. The results of diagnosis and treatment of 140 patients, suffering an acute biliary pancreatitis, were analyzed. There were 33 men and 107 women, ageing 22 – 88 yrs, and median age – 57.6 yrs old. In all the patients biliary origin of pancreatitis was diagnosed in accordance to criteria, proposed by Holland’s Investigation Group for Pancreatitis Studying. The patients were divided into two groups, in accordance to periods for conduction of decompressive treatment procedures. Into Group 1 were included 70 patients, in whom decompressive surgical interventions were performed in the first 72 h after primary appearance of abdominal pain, independent from time of admittance to the clinic, and into Group 2 – 70 patients, in whom the wait–and–see tactics with conservative therapy was applied in accordance to the disease severity, decompressive methods were used later than 72 h after the disease beginning. Results. In patients of Group1 49 fibrogastroduodenoscopies (FGDS) with papillosphincterotomy and lithoextraction, 10 transcutaneous puncture drainages, 13 laparoscopic cholecystectomies with external draining of extrahepatic biliary ducts (in 5 patients laparoscopic choledochoscopy with lithoextraction) were performed. Necrotic forms of an acute pancreatitis were revealed in 26 (37.1%) patients, in 12 (46.2%) of them the infectioning have occurred. Average duration of treatment have constituted 15.48 days, and lethality – 8.57%. In patients of Group 2 22 FGDS with papillosphincterotomy and lithoextraction,5 transcutaneous puncture drainages, 6 cholecystectomies (of them 5 – with external draining of common biliary duct), 18 necrsequestrectomies (in 11 patients cholecystectomy was done additionally and in 7 – drainage of extrahepatic biliary ducts) were performed. Necrotic forms of an acute pancreatitis have developed in 38 (54.3%) patients, of them in 25 (65.8%) the infectioning have occurred. Average duration of treatment have constituted 22.2 days, and lethality – 17.14%. Conclusion. Application of decompressive operative interventions for elimination of biliary hypertension in patients, suffering an acute biliary pancreatitis in the first 72 h after the disease beginning, make possible to reduce the occurrence rate for necrotic and infected forms, the disease severity, the lethality level and the stationary state duration.